Does This Move Make Merck Stock a Buy? @Themotleyfool #Stocks $MRK $VRNA
UNION COUNTY, NEW JERSEY, JUL 20 – Bragar Eagel & Squire alleges Merck misled investors about Gardasil revenue and growth, causing a stock price drop of over 9%, and seeks class action on behalf of long-term shareholders.
Summary by Benzinga
2 Articles
2 Articles
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium